Wenfeng H. Li
No. 2 Of Fuxue Lane
Wenzhou, 325000, China
Wenzhou, 325000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Expert consensus on the detection and clinical application of tumor mutational burden.
Journal: Cancer biology & medicine
Published: February 18, 2026
Non-α-biased IL-2 enhances both intratumoral and subcutaneous CpG/α-OX40 therapy, unleashing systemic antitumor immunity in mice.
Journal: Journal for immunotherapy of cancer
Published: November 25, 2025
International guidelines on the diagnosis and treatment of NUT carcinoma.
Journal: Innovation (Cambridge (Mass.))
Published: April 11, 2025
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration.
Journal: Cancer biology & medicine
Published: April 09, 2025
An alternative EGFR activation by patient-derived R252C mutation promotes cancer progression.
Journal: Nature communications
Published: March 26, 2025
Preparation and Characterization of Silica-Coated Sodium Alginate Hydrogel Beads and the Delivery of Curcumin.
Journal: Journal of biomaterials science. Polymer edition
Published: July 02, 2024
The heat shock protein DNAJB8 inhibits pseudorabies virus replication by autophagy.
Journal: Veterinary microbiology
Published: April 21, 2024
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations.
Journal: Innovation (Cambridge (Mass.))
Published: March 15, 2024
Continuation of immunotherapy beyond progression is beneficial to the survival of advanced non-small-cell lung cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: September 27, 2023
Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populations.
Journal: Therapeutic advances in medical oncology
Published: December 09, 2022
Optimization of whole-cell vaccines with CpG/αOX40/cGAMP to strengthen the anti-tumor response of CD4+ T cells in melanomas.
Journal: Journal of cancer research and clinical oncology
Published: April 17, 2022
Last Updated: 09/26/2026